{
    "id": 2699,
    "fullName": "FOXA1 dec exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "FOXA1 dec exp indicates decreased expression of the Foxa1 protein. However, the mechanism causing the decreased expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 3169,
        "geneSymbol": "FOXA1",
        "terms": [
            "FOXA1",
            "HNF3A",
            "TCF3A"
        ]
    },
    "variant": "dec exp",
    "createDate": "12/08/2014",
    "updateDate": "05/13/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1427,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the siRNA knockdown of FOXA1 enhanced the efficacy of Taxol (paclitaxel) in ER-positive breast cancer cells, including Taxol (paclitaxel)-resistant cells in culture (PMID: 25422910).",
            "molecularProfile": {
                "id": 2518,
                "profileName": "FOXA1 dec exp"
            },
            "therapy": {
                "id": 1103,
                "therapyName": "Paclitaxel",
                "synonyms": null
            },
            "indication": {
                "id": 60075,
                "name": "estrogen-receptor positive breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 1274,
                    "pubMedId": 25422910,
                    "title": "Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25422910"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2518,
            "profileName": "FOXA1 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}